Invesco
DSCI

Invesco’s Derma Sciences, Inc. Common Stock (DE) DSCI Stock Holding History

Invesco’s Portfolio DSCI Stock Details DSCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-26,031
Closed -$348K – 4425
2013
Q2 		$348K Buy
+26,031
New +$335K ﹤0.01% 3439

Other funds holding DSCI

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
RCM
Raging Capital Management Rocky Hill, New Jersey $18.2M AUM 17.75% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
TAM
THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Invesco's DSCI Position: Q3 2013 in Review

Invesco sold out of Derma Sciences, Inc. Common Stock (DE) (DSCI) in Q3 2013, closing a stake of 26,031 shares — an estimated $348K sold.

Invesco first reported a position in DSCI in Q2 2013 and held it in 1 quarter. The position peaked at $348K in Q2 2013. 52 funds tracked by Wall St. Rank hold DSCI as of Q3 2013.

  • Invesco reported no remaining Derma Sciences, Inc. Common Stock (DE) position as of Q3 2013 after selling out during the quarter.
  • Invesco sold 26,031 Derma Sciences, Inc. Common Stock (DE) shares in Q3 2013, an estimated $348K.
  • Invesco first reported a position in Derma Sciences, Inc. Common Stock (DE) in Q2 2013 and held it in 1 quarter.
  • Invesco's Derma Sciences, Inc. Common Stock (DE) position peaked at $348K in Q2 2013.
  • 52 funds tracked by Wall St. Rank held Derma Sciences, Inc. Common Stock (DE) as of Q3 2013.

Based on Invesco's 13F filing for Q3 2013, filed 13 Nov 2013.